Efficacy and safety of canagliflozin in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
about
Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy.Renal Effects of SGLT-2 Inhibitors and Other Anti-diabetic Drugs: Clinical Relevance and Potential Risks.Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).Cardiovascular effects of sodium glucose cotransporter 2 inhibitors.
P2860
Efficacy and safety of canagliflozin in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy and safety of canagli ...... randomized controlled trials.
@ast
Efficacy and safety of canagli ...... randomized controlled trials.
@en
type
label
Efficacy and safety of canagli ...... randomized controlled trials.
@ast
Efficacy and safety of canagli ...... randomized controlled trials.
@en
prefLabel
Efficacy and safety of canagli ...... randomized controlled trials.
@ast
Efficacy and safety of canagli ...... randomized controlled trials.
@en
P2093
P2860
P1433
P1476
Efficacy and safety of canagli ...... randomized controlled trials.
@en
P2093
Ming Yue Xiao
P2860
P356
10.1097/MD.0000000000005473
P407
P577
2016-11-01T00:00:00Z